X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs ELDER PHARMA - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA ELDER PHARMA ABBOTT INDIA/
ELDER PHARMA
 
P/E (TTM) x 40.3 -0.2 - View Chart
P/BV x 10.7 0.1 10,630.7% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 ABBOTT INDIA   ELDER PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
ELDER PHARMA
Jun-14
ABBOTT INDIA/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs6,110380 1,607.9%   
Low Rs3,996188 2,125.5%   
Sales per share (Unadj.) Rs1,552.2491.2 316.0%  
Earnings per share (Unadj.) Rs188.8-3.2 -5,934.3%  
Cash flow per share (Unadj.) Rs196.414.4 1,363.3%  
Dividends per share (Unadj.) Rs55.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs796.6376.5 211.6%  
Shares outstanding (eoy) m21.2520.54 103.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.30.6 563.0%   
Avg P/E ratio x26.8-89.3 -30.0%  
P/CF ratio (eoy) x25.719.7 130.5%  
Price / Book Value ratio x6.30.8 840.9%  
Dividend payout %29.10-   
Avg Mkt Cap Rs m107,3765,833 1,840.7%   
No. of employees `0003.3NA-   
Total wages/salary Rs m3,9372,179 180.7%   
Avg. sales/employee Rs Th9,929.3NM-  
Avg. wages/employee Rs Th1,185.1NM-  
Avg. net profit/employee Rs Th1,207.7NM-  
INCOME DATA
Net Sales Rs m32,98510,089 326.9%  
Other income Rs m1,170257 455.9%   
Total revenues Rs m34,15510,346 330.1%   
Gross profit Rs m5,245-792 -662.3%  
Depreciation Rs m162361 44.8%   
Interest Rs m382,756 1.4%   
Profit before tax Rs m6,215-3,653 -170.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m2,203125 1,760.0%   
Profit after tax Rs m4,012-65 -6,139.4%  
Gross profit margin %15.9-7.8 -202.6%  
Effective tax rate %35.4-3.4 -1,034.5%   
Net profit margin %12.2-0.6 -1,877.8%  
BALANCE SHEET DATA
Current assets Rs m22,6559,240 245.2%   
Current liabilities Rs m6,6819,998 66.8%   
Net working cap to sales %48.4-7.5 -644.8%  
Current ratio x3.40.9 366.9%  
Inventory Days Days6546 139.9%  
Debtors Days Days2960 48.6%  
Net fixed assets Rs m83510,124 8.3%   
Share capital Rs m213206 103.3%   
"Free" reserves Rs m16,7155,582 299.4%   
Net worth Rs m16,9287,734 218.9%   
Long term debt Rs m04,889 0.0%   
Total assets Rs m24,16222,882 105.6%  
Interest coverage x163.7-0.3 -50,321.4%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x1.40.4 309.6%   
Return on assets %16.811.8 142.5%  
Return on equity %23.7-0.8 -2,804.8%  
Return on capital %36.922.3 165.6%  
Exports to sales %03.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m369307 120.2%   
Fx outflow Rs m3,807125 3,038.0%   
Net fx Rs m-3,438181 -1,896.3%   
CASH FLOW
From Operations Rs m1,52711,754 13.0%  
From Investments Rs m-2,148-561 383.3%  
From Financial Activity Rs m-1,024-6,762 15.1%  
Net Cashflow Rs m-1,6464,432 -37.1%  

Share Holding

Indian Promoters % 0.0 39.6 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 7.5 105.3%  
FIIs % 0.1 16.8 0.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 36.1 47.4%  
Shareholders   18,270 16,479 110.9%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   WOCKHARDT  J.B.CHEMICALS  ORCHID PHARMA LTD  DISHMAN PHARMA  FULFORD INDIA  

Compare ABBOTT INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 318 Points Lower; Auto and Metal Stocks Witness Selling(Closing)

India share markets continued to witness selling pressure during closing hours and ended their day on a negative note.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY19); Net Profit Up 70.8% (Quarterly Result Update)

Aug 20, 2018 | Updated on Aug 20, 2018

For the quarter ended June 2018, ABBOTT INDIA has posted a net profit of Rs 824 m (up 70.8% YoY). Sales on the other hand came in at Rs 8 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY18); Net Profit Up 137.9% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 137.9% YoY). Sales on the other hand came in at Rs 8 bn (up 10.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jul 18, 2019 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS